Intellipharmaceutics International Inc. (IPCI)

[stocking4ms]

There is a 10/17 filing:
....On October 16, 2018 the Company completed an underwritten public offering in the US....resulting in the sale of 2,775,231 common shares, pre-funded warrants exercisable for 16,563,335 common shares, at an exercise price of US$0.01/sh, and warrants exercisable for 20M common shares, at an exercise price of US$0.75/sh. The Company received gross proceeds of approximately US$14.3M, prior to deducting discount/commissions/expenses.
As of the date of this report, the Company believes that it has regained compliance with Nasdaq’s stockholders’ equity requirement....the Company believes its stockholders’ equity is in excess of US$2.5M.
...The Company is awaiting confirmation from Nasdaq that it has achieved compliance with the US$2.5M stockholders’ equity requirement and intends to make a further announcement upon receiving such notice of compliance.